DiSTABiF, Università degli Studi della Campania "Luigi Vanvitelli", Caserta, Italy.
School of Chemical and Biotechnology, SASTRA University, Thanjavur, India.
J Biomol Struct Dyn. 2022 Jul;40(11):5069-5078. doi: 10.1080/07391102.2020.1867641. Epub 2020 Dec 31.
The disease Tuberculosis (TB) is caused by a bacterium called (). The bacterial cell-wall consists of peptidoglycan layer maintains the cellular integrity and cell viability. The main problem resides in the cell cycle of in its quiescent form which is not targeted by any drugs hence there is an immediate need for new antibiotics to target the cell wall. The current study deals with the dTDP-4-dehydrorahmnose reductase (RmlD) which is the final enzyme in the series of cell-wall proteins of . The RmlD is a part of Carbohydrate biosynthesis has been considered as a good drug target for the novel class of antibiotics. Our study begins with the protein structure prediction, Homology studies were conducted using the Phyre2 web server. The structure is then refined and subjected to molecular dynamics simulations for 50 ns using GROMACS. The clustering analysis has been carried out and generated 41 clusters with 2 Å as the cut-off. Blind docking virtual screening was performed against RmlD protein using the Super Natural-II database with AutoDock4.0. its results helped to screen top ligands based on best binding energies. In both dockings, there are some common residues in which the ligands are interacting and forming the Hydrogen bonds such as Asp-105, Val-158, Thr-160, Gly-161, Arg-224, Arg-256. The ligand-567 giving the best results by being in the top-3 of all the clusters in both blind docking as well as the active-site docking. Hence ligand-567 can be a potential inhibitor of RmlD which can further inhibit the cell-wall synthesis of Communicated by Ramaswamy H. Sarma.
结核病(TB)是由一种叫做 ()的细菌引起的。细菌细胞壁由肽聚糖层组成,维持细胞的完整性和细胞活力。主要问题在于处于静止状态的 ()的细胞周期,目前没有任何药物可以靶向该周期,因此急需新的抗生素来靶向细胞壁。本研究涉及 dTDP-4-脱水赖氨醇还原酶(RmlD),它是细胞壁蛋白系列中的最后一种酶。RmlD 是碳水化合物生物合成的一部分,已被认为是新型抗生素的一个很好的药物靶点。我们的研究始于蛋白质结构预测,使用 Phyre2 网络服务器进行同源性研究。然后对结构进行细化,并使用 GROMACS 进行 50ns 的分子动力学模拟。进行了聚类分析,并生成了 41 个簇,以 2Å 为截止值。使用 AutoDock4.0 对 RmlD 蛋白进行盲法对接虚拟筛选,使用 SuperNatural-II 数据库。其结果有助于根据最佳结合能筛选出顶级配体。在两种对接中,有一些共同的残基,配体在这些残基中相互作用并形成氢键,如 Asp-105、Val-158、Thr-160、Gly-161、Arg-224、Arg-256。配体-567 在盲法对接和活性位点对接中都在所有簇的前 3 名中给出了最佳结果。因此,配体-567 可能是 RmlD 的潜在抑制剂,它可以进一步抑制细胞壁的合成。